Work

Juniper Point has the experience to confidently and efficiently guide your business interests. Below are a select group of our dynamic partners.


Pipeline

Below is a select group of our global partners and their focus.

Company
Focus
Rare disease, centronuclear myopathies (CNM)
Public/Private
Private
Stage
Preclinical
Company
Focus
Drug discovery and partnership development
Public/​Private
Frankfurt Stock Exchange
Stage
Profitable.
Co-owned pipeline >100 drugs
Discovery – Phase 2
Company
Focus
Novel antibiotics, metalloenzyme platform
Public/Private
Private, Series A/non-dilutive funding grants
Stage
Discovery
Company
Focus
CINV and post operative pain products
Public/Private
NASDAQ
Stage
Commercial
Company
Focus
DNA/RNA vaccines, UNITE technology platform
Public/Private
Private, partnerships
Stage
Discovery – Phase 2
Company
Focus
Optimized biologics for cancer, infectious disease and orphan diseases
Public/Private
Private, partnerships/non-dilutive funding grants
Stage
Discovery – Phase 1
Company
Focus
Medical devices for intracranial bleeding
Public/Private
NASDAQ/Stockholm First North Premier
Stage
Commercial
Company
Focus
Improving upon existing oncology therapies
Public/Private
NASDAQ
Stage
Clinical proof-of-concept – through pivotal studies